X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (42) 42
humans (36) 36
endocrinology & metabolism (29) 29
diabetes (27) 27
diabetes mellitus (20) 20
diabetes mellitus, type 2 - drug therapy (19) 19
type 2 diabetes (19) 19
female (17) 17
male (16) 16
middle aged (15) 15
aged (14) 14
mortality (14) 14
risk factors (10) 10
care and treatment (9) 9
hypoglycemic agents - therapeutic use (9) 9
insulin (9) 9
risk (9) 9
adamantane - analogs & derivatives (8) 8
cardiovascular diseases (8) 8
heart diseases (8) 8
heart failure (8) 8
management (8) 8
mellitus (8) 8
adult (7) 7
cardiac & cardiovascular systems (7) 7
clinical trials (7) 7
diabetes mellitus, type 2 - complications (7) 7
diabetics (7) 7
dipeptidyl peptidase-4 inhibitors (7) 7
double-blind method (7) 7
glycemic control (7) 7
hypoglycemia (7) 7
hypoglycemic agents - administration & dosage (7) 7
myocardial infarction (7) 7
outcomes (7) 7
patients (7) 7
abridged index medicus (6) 6
analysis (6) 6
arteriosclerosis (6) 6
association (6) 6
dipeptidyl-peptidase iv inhibitors - therapeutic use (6) 6
disease (6) 6
dosage and administration (6) 6
health aspects (6) 6
kidney diseases (6) 6
medicine, general & internal (6) 6
patient outcomes (6) 6
saxagliptin (6) 6
sodium (6) 6
usage (6) 6
adamantane - adverse effects (5) 5
adamantane - therapeutic use (5) 5
cardiovascular disease (5) 5
cardiovascular outcomes (5) 5
cerebral infarction (5) 5
complications and side effects (5) 5
dapagliflozin (5) 5
death (5) 5
dipeptides - adverse effects (5) 5
dipeptides - therapeutic use (5) 5
empagliflozin (5) 5
glucose (5) 5
heart attacks (5) 5
hospitalization (5) 5
hyperglycemia (5) 5
israel (5) 5
metformin (5) 5
prevention (5) 5
type-2 (5) 5
aged, 80 and over (4) 4
algorithms (4) 4
beta-cell function (4) 4
blood pressure (4) 4
body mass index (4) 4
coronary artery disease (4) 4
creatinine (4) 4
diabetes mellitus, type 2 (4) 4
diabetes mellitus, type 2 - blood (4) 4
diabetes therapy (4) 4
double-blind (4) 4
drug therapy (4) 4
epidermal growth factor receptors (4) 4
glucose transporter (4) 4
glycated hemoglobin a - metabolism (4) 4
health risk assessment (4) 4
health risks (4) 4
heart-failure (4) 4
hypoglycemic agents - adverse effects (4) 4
insulin - administration & dosage (4) 4
internal medicine (4) 4
meta-analysis (4) 4
metaanalysis (4) 4
peripheral vascular disease (4) 4
pharmacology & pharmacy (4) 4
research (4) 4
retrospective studies (4) 4
risk assessment (4) 4
safety (4) 4
sitagliptin (4) 4
sodium-glucose transporter 2 inhibitors (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes Research and Clinical Practice, ISSN 0168-8227, 2016, Volume 120, pp. S20 - S20
Journal Article
Diabetes Research and Clinical Practice, ISSN 0168-8227, 10/2016, Volume 120, pp. S20 - S20
Journal Article
Diabetes Care, ISSN 0149-5992, 12/2016, Volume 39, Issue 12, pp. e227 - e227
Journal Article
Diabetes Care, ISSN 0149-5992, 2016, Volume 39, Issue 12, p. e227
Journal Article
Nature Reviews Cardiology, ISSN 1759-5002, 04/2016, Volume 13, Issue 4, pp. 185 - 186
The latest findings from the EMPA-REG OUTCOME trial show a 34% reduction in hospitalization for heart failure or cardiovascular death in patients receiving... 
Hypoglycemic Agents - therapeutic use | Hospitalization | Diabetes Mellitus, Type 2 - drug therapy | Humans | Heart Failure - drug therapy
Journal Article
Journal Article
Nature Reviews Cardiology, ISSN 1759-5002, 04/2016, Volume 13, Issue 4, p. 185
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2019, Volume 380, Issue 4, pp. 347 - 357
Journal Article
Journal Article
Journal of Diabetes, ISSN 1753-0393, 01/2020, Volume 12, Issue 1, pp. 5 - 7
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 02/2019, Volume 21, Issue 2, pp. 340 - 348
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 05/2018, Volume 20, Issue 5, pp. 1102 - 1110
Aim To describe the baseline characteristics of participants randomized in the Dapagliflozin Effect on CardiovascuLAR Events (DECLARE‐TIMI 58) trial, the... 
cardiovascular outcomes | CVOTs | type 2 diabetes | dapagliflozin | SGLT2 inhibitors | METFORMIN | PLACEBO | 2 INHIBITORS | INADEQUATE GLYCEMIC CONTROL | BLOOD-PRESSURE | ADD-ON THERAPY | BODY-WEIGHT | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | TYPE-2 DIABETES-MELLITUS | Metformin - therapeutic use | Prevalence | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Cardiovascular Diseases - complications | Clinical Trials, Phase III as Topic | Drug Therapy, Combination - adverse effects | Benzhydryl Compounds - adverse effects | Multicenter Studies as Topic | Cardiovascular Diseases - epidemiology | Diabetic Cardiomyopathies - prevention & control | Female | Glucosides - therapeutic use | Diabetic Angiopathies - prevention & control | Benzhydryl Compounds - therapeutic use | Diabetes Mellitus, Type 2 - complications | Glucosides - adverse effects | Body Mass Index | Hypoglycemic Agents - therapeutic use | Diabetic Angiopathies - chemically induced | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Double-Blind Method | Obesity - complications | Risk Factors | Diabetic Cardiomyopathies - epidemiology | Diabetic Angiopathies - epidemiology | Aged | Cardiovascular Diseases - chemically induced | Diabetes Mellitus, Type 2 - drug therapy | Diabetic Cardiomyopathies - chemically induced | Insulin - therapeutic use | Cohort Studies | Type 2 diabetes | Hypertension | Glycosylated hemoglobin | Aspirin | Statins | Diabetes mellitus | Insulin | Patients | Risk factors | Body mass index | Arteriosclerosis | Hemoglobin | Clopidogrel | Diabetes | Metformin | Diabetes mellitus (non-insulin dependent) | Smoking
Journal Article
Journal Article